Illinois Eye Center
Peoria, Illinois 61615
3 studies enrolling now · 11 studies all time
What they study most
Adenoviral Conjunctivitis, Age-Related Macular Degeneration, BRAF V600E-mutant Metastatic Colorectal Cancer, Bacterial Conjunctivitis, Cervical Cancer, Geographic Atrophy, Glaucoma, Glaucoma and Ocular Hypertension, Macular Degeneration, Neovascular Age-related Macular Degeneration
Studies at this site
- A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy — Recruiting now
- Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer — Recruiting now
- Clarifying the Optimal Application of SLT Therapy Trial — Recruiting now
- Avacincaptad Pegol Open-Label Extension for Patients With Geographic Atrophy — Completed
- A Phase 3 Safety and Efficacy Study of Intravitreal Administration of Zimura (Complement C5 Inhibitor) — Completed
- Evaluate the Safety and Effectiveness of iSTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma. — Running, not enrolling
- ZIMURA in Combination With LUCENTIS in Patients With Neovascular Age Related Macular Degeneration (NVAMD) — Completed
- Safety, Tolerability, and Efficacy Study of UBX1325 in Patients With Neovascular Age-Related Macular Degeneration (ENVISION) — Completed
- Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer — Completed
- Treatment of Adenoviral Conjunctivitis With SHP640 Compared to Povidone-iodine (PVP-I) and Placebo — Stopped early
- Treatment of Bacterial Conjunctivitis With SHP640 Compared to PVP-Iodine and Placebo — Completed